Ketofol Versus Propofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients.

About This Study

This study is a double blind randomized controlled trial. The investigators randomized ASA III and IV patients who underwent cholangiopancreatography. The investigators gave Propofol or Ketofol and compared the outcomes. The primary outcome was security (respiratory depression / hypoventilation).

Conditions Studied

Interventions

• •Profofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients
• •Ketofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients

Eligibility

Inclusion Criteria:

* 18 years old
* ASA III and IV
* Submitted to retrograde cholangiopancreatography

Exclusion Criteria:

* Patient refuse
* ASA I, II and V
* Ketamine contraindications
* Allergies to Propofol, Ketamine, dexamethasone, paracetamol, metamizole, ondanseteon or other.
* General anesthesia necessary I
* Incapacitaty to sign or absence of patient legal representation.